Garrett Wealth Advisory Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Garrett Wealth Advisory Group's NVS Position: Q1 2026 in Review
Garrett Wealth Advisory Group sold out of Novartis (NVS) in Q1 2026, closing a stake of 1,485 shares — an estimated $205K sold.
Garrett Wealth Advisory Group first reported a position in NVS in Q3 2019 and held it in 2 quarters. The position peaked at $205K in Q4 2025. 1,604 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Garrett Wealth Advisory Group reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
- Garrett Wealth Advisory Group sold 1,485 Novartis shares in Q1 2026, an estimated $205K.
- Garrett Wealth Advisory Group first reported a position in Novartis in Q3 2019 and held it in 2 quarters.
- Garrett Wealth Advisory Group's Novartis position peaked at $205K in Q4 2025.
- 1,604 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Garrett Wealth Advisory Group's 13F filing for Q1 2026, filed 27 Apr 2026.